Supira Medical Gains FDA Nod for SUPPORT II Trial
LOS GATOS, Calif., April 8, 2026 Supira Medical has achieved a major regulatory milestone with the U.S. Food and...
Alzheimer’s Disease Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody NSCLC Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
LOS GATOS, Calif., April 8, 2026 Supira Medical has achieved a major regulatory milestone with the U.S. Food and...
TUCSON, Ariz., Feb. 12, 2026 — Picard Medical, parent company of SynCardia Systems, announced a landmark bridge-to-transplant milestone at...
